万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://journals.sagepub.com/home/cara
3、投稿网址：https://mc.manuscriptcentral.com/cart
4、官网邮箱：mats.brittberg@telia.com（主编）
5、官网电话：(+46) 702183652（主编）
6、期刊刊期：季刊，逢季首月出版。
2021年5月29日星期六
投稿须知【官网信息】
Manuscript Submission Guidelines:
Now in MEDLINE!
CARTILAGE is the official journal of the International Cartilage Regeneration & Joint Preservation Society (ICRS).
The objective of CARTILAGE is to bridge a gap in the literature by focusing on cartilage research from both clinical and basic science perspectives. The journal serves as a focal point and a forum for the exchange of ideas for the many researchers and practitioners involved in cartilage biology and repair therapy. CARTILAGE will publish articles related to cartilage repair, growth of cartilage, cartilage function, and cartilage transplantation, including regeneration. A primary objective is to foster the cross-fertilization of the findings from clinical and basic sciences of the myriad disciplines involved in cartilage research (e.g., developmental biology, biomechanics, imaging, matrix biology, tissue regeneration) and repair (e.g., joint protection). The journal will publish full-length original manuscripts (4000 or fewer words) and brief communications (1500 or fewer words) on all aspects of cartilage including, but not limited to articular, meniscus, airway, auricular, nasal septum, rib, and growth plate. Manuscripts may address clinical, laboratory, surgical approaches, and therapeutic research. Narrative reviews will be considered when they describe cutting-edge and evolving developments and discuss these developments in light of underlying theory. Systematic reviews will be considered when they are especially suitable for critiquing and summarizing evidence relevant to focused questions. Editorials and letters are encouraged.
Editorial Policy
Manuscripts are accepted for consideration on the condition that they are contributed solely to CARTILAGE. No substantial part of a paper (except for a scientific abstract or poster) may have been published elsewhere. All work must be original. Receipt of your manuscript by the journal will be acknowledged and a decision regarding its status made as soon as possible. All manuscripts are subject to editorial review. Manuscripts will be initially reviewed by the Editor-in-Chief or an Associate Editor. Some manuscripts that are deemed inappropriate for the journal or very low priority by the editorial staff may be returned without review. If eligible for publication, the manuscript will be reviewed by 2 or more external, independent reviewers. Revisions, if requested, will require resubmission within 90 days, unless otherwise specified. Manuscripts must be written in acceptable English. Manuscripts submitted in poor English will be returned without review (see “English Language Editing Services” section below).
1. Manuscript Submission
Please read and follow the instructions to authors outlined below. Failure to follow these instructions will delay processing of the manuscript.
Manuscripts are to be submitted at http://mc.manuscriptcentral.com/cart, where authors will be required to set up an online account in the SAGE Track system powered by ScholarOne. Authors will be guided stepwise through the creation and uploading of all manuscript files. All correspondence, including notification of the Editor's decision and requests for revision, will take place via e-mail. Upon acceptance of an article, authors will be asked to complete a Journal Contributor's Publishing Agreement. An e-mail will be sent to the corresponding author confirming acceptance of the manuscript together with a link to the online version of this agreement.
1.1 Authorship
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
(i) made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data,
(ii) drafted the article or revised it critically for important intellectual content,
(iii) approved the version to be published.
Please refer to the ICMJE Authorship guidelines.
1.2 Acknowledgments
Any acknowledgments should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
All contributors who do not meet the criteria for authorship should be listed in an ‘Acknowledgments’ section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.
1.3 Conflict of Interest Statement
If the author or co-authors have financial interest in products relevant to the manuscript, the nature of these should be disclosed after the reference section. Furthermore, in the Journal Contributor's Publishing Agreement sent out to the authors when a paper has been accepted, the authors need to very carefully declare if they have any affiliations with or any involvement in any company, organization or business indicating any financial interest or non-financial interest in the subject matter or materials discussed in their manuscript.
1.4 Declaration of Conflicting Interest
It is the policy of CARTILAGE to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.
1.5 Reviewers
CARTILAGE is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for CARTILAGE can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the Publons website.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process
1.6 Publication Ethics
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.
1.6.1 Contributor's Publishing Agreement
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit the SAGE Author Gateway.
1.6.2 Plagiarism
CARTILAGE and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
1.6.3 Prior Publication
If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.
1.7 Permissions
Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere before they are published in CARTILAGE. A copy of the written permission must be included with the manuscript submission.
For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
2. Submission Letter
The manuscript is to be accompanied by a cover letter that states (1) all the authors have read and approved the final manuscript, (2) all authors have read and approve of the data being presented in the manuscript, (3) the full name, address, e-mail address, phone, and fax number of the individual to whom correspondence concerning the manuscript is to be sent. The cover letter should be addressed to:
Mats Brittberg, MD, PhD
Editor-in-Chief, CARTILAGE
Ringvägen 80
Varberg, Halland, 43243
Sweden
Phone: (+46) 702183652
Fax: (+46) 300465415
mats.brittberg@telia.com
2.1 Revisions
When submitting your revised manuscript, you will be able to respond to the comments made by the reviewer(s) in the space provided in the author center. You can use this space to document any changes you make to the original manuscript. In order to expedite the processing of the revised manuscript, please be as specific as possible in your response to the reviewer(s). All answers to the reviewers questions should be presented point to point and the answers should be positioned at the end of the manuscript. Changes should be notated in the manuscript with a yellow text marker.
3. Manuscript Format
Manuscript format should comply with the International Committee of Medical Journal Editors' Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org) except where otherwise specifically indicated. In all matters of style, please consult the Manual of Style (10th ed.) published by the American Medical Association. Number each page sequentially, including the title page, abstract, text, references, figure legends, and tables.
Each of the following sections should be included: Title page (with funding declaration), Abstract, Introduction, Method, Results, Discussion, Acknowledgments (when appropriate), References, Conflict of Interest statement, Figure legends, each individual figure and table. All text should be submitted as MS Word (*.doc) files.
3.1 Title Page
On the title page, please include all of the following:
A concise and informative title (do not use abbreviations or acronyms).
The names, degrees, and professional affiliation (position, department, institution, place) of all authors.
The name of the institution where the work reported was done.
Acknowledgment of grant support when appropriate.
Complete mailing address, telephone, and fax of corresponding author; e-mail addresses of all authors.
3.2 Abstract
Abstracts should be fewer than 250 words. Abstracts for original contributions should be divided into sections, according to (1) Objective; (2) Design—if clinical to include setting, selection of patients, details on the intervention, outcome measures, etc.; if laboratory research to include details on methods; (3) Results—data to be included (comments such as "will be presented" or "to be discussed" are not acceptable); (4) Conclusions. Abstracts should summarize the main points of the paper and be descriptive, narrative, informative, and include only information that is in the article. Avoid abbreviations or spell out on first use.
Classification criteria should be reported on patients (where relevant) by a brief description of the clinical features of patients and by reference to the criteria used.
Provide 3-5 pertinent keywords at the end of the abstract.
3.3 Body of the Text
The text of the paper should be no longer than 15-20 double-spaced typed pages in most cases.
For most original manuscripts the subheadings include Introduction, Methods, Results, and Discussion.
3.3.1 The Introduction
The Introduction should be no longer than 2-3 paragraphs; it should provide background and rationale for the study and specifically state the study’s objectives or hypotheses.
3.3.2 The Methods
The Methods section should describe how participants were assembled and selected, then describe study procedures including any interventions, measurements, and data collection techniques.
3.3.3 Research Ethics and Patient Consent
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants.
All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.
Clinical trials
CARTILAGE conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.]
Reporting guidelines
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
Research Data
The journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the SAGE Research Data policy pages.
Subject to appropriate ethical and legal considerations, authors are encouraged to:
share your research data in a relevant public data repository
include a data availability statement linking to your data. If it is not possible to share your data, we encourage you to consider using the statement to explain why it cannot be shared.
cite this data in your research
……
更多详情：
https://journals.sagepub.com/author-instructions/CAR
